Senti Biosciences（SNTI.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

风投/私募43.51%
公众及其他35.76%
上市公司15.80%
机构投资者3.68%
个人与内部人士1.24%

主要股东

主要股东最新
股东
Celadon Partners	31.39%	977.70 万	0.00%	+0	2026/07/14
Celadon Partners	31.39%	977.70 万	0.00%	+0	2026/07/14
New Enterprise Associates, Inc.	12.12%	377.56 万	0.10%	+0	2026/03/31
New Enterprise Associates, Inc.	12.12%	377.56 万	0.00%	+0	2026/06/30
Bayer Aktiengesellschaft	9.02%	280.98 万	0.08%	+543.00	2026/03/27
Bayer Aktiengesellschaft	9.02%	280.98 万	0.00%	+0	2026/03/27
PharmaEssentia Corporation	6.78%	211.10 万	0.00%	+0	2026/06/30
PharmaEssentia Corporation	6.78%	211.10 万	0.00%	+0	2026/06/30
Nantahala Capital Management, LLC	2.85%	88.80 万	0.02%	+0	2026/03/31
Vanguard Capital Management, LLC	2.02%	62.87 万	0.00%	+0	2026/06/30
Vanguard Capital Management, LLC	2.02%	62.87 万	0.00%	+0	2026/06/30
Timothy LuCo-Founder, CEO & Director	0.99%	30.68 万	0.47%	+14.52 万	2026/06/30
Timothy LuCo-Founder, CEO & Director	0.99%	30.68 万	0.47%	+14.52 万	2026/06/30
Geode Capital Management, LLC	0.60%	18.71 万	0.06%	-2.00 万	2026/06/30
Geode Capital Management, LLC	0.60%	18.71 万	0.06%	-2.00 万	2026/06/30
Citadel Advisors LLC	0.34%	10.71 万	0.34%	+10.71 万	2026/06/30
Jane Street Group, LLC	0.17%	5.25 万	0.17%	+5.25 万	2026/06/30
Kanya RajangamPresident, Head of Research & Development and Chief Medical Officer	0.17%	5.22 万	0.06%	+1.92 万	2026/06/30
Kanya RajangamPresident, Head of Research & Development and Chief Medical Officer	0.17%	5.22 万	0.06%	+1.92 万	2026/06/30
Menlo Ventures Management, L.P.	0.11%	3.57 万	0.00%	+0	2026/06/30